Early Look

Wednesday, November 11, 2026

After stocks declined on Tuesday following a hotter than expected CPI core inflation reading, leading to a surge in Treasury yields and a broad market sell off, U.S. stocks futures are surging overnight, especially in the tech space as the Ai trade gets a boost overnight. Neocloud provider CoreWeave (CRWV), whose shares gave tumbled in recent months on debt concerns, has shares soar over 14% overnight after providing better-than-expected quarterly revenue and raised its revenue outlook, fueled by booming customer demand for AI compute capacity. Revenue increased by more than $1 billion sequentially and adjusted operating margins reaching double digits a quarter ahead of plan, helping lift shares and giving a boost to semis, and other AI data center, AI infrastructure names. Nasdaq futures are surging over 500 points or nearly 2%, as the QQQs top $687, moving back above its 200dma of $681.40.

Treasury yields rose on Tuesday as sticky inflation raises the prospect of a steep interest rate increase by the Fed in December. October CPI comes in at a surprisingly high 0.4%, shortly after Fed's Waller said an oversized rate increase by half of a percent could be justified if prices keep misbehaving. The resulting repricing of expectations pushed the 10-year yield briefly above 5%. A 10-year auction in the middle of the selloff shows tepid demand. The 10-year yield settles at 4.982%, up 12 bps and the two-year has its highest daily increase since April 2025, rising 18bps to 4.725% (bond markets closed for Veteran’s Day).

In Asian markets, The Nikkei Index advanced 789 points to 61,248, the Shanghai Index rose 16 point to 3,680, the Kospi climbed 24 points or about 3% to 838, and the Hang Seng Index fell -241 points to 24,315. In Europe, the German DAX is up 175 points to 26,525, while the FTSE 100 is rising 40 points to 10,792. Reminder the U.S. bond market is closed on Wednesday in observance of Veterans Day and there are no economic events scheduled for Wednesday.

• The Dow Jones Industrial Average fell -157.86 points, or 0.30%, to 52,231.89
• The Nasdaq Composite dropped -187.26 points, or 0.74%, to 25,065.87
• The Russell 2000 Index declined -19.44 points, or 0.68% to 2,821.38

• Earnings After the Close: AGBK AGRO ALVO AVEX CAE CINT CTVA DDI DGII ENS FNV ITRG OPRX PXLW TK TNK XAIR

• Stifel Healthcare Conference, 11/11-11/13, in New York

• Costco Wholesale Corporation (COST) declares $30 special cash dividend and reauthorizes stock repurchase program and reauthorizes common stock repurchase program of up to $4B.
• Fossil Group (FOSL) Q3 adj EPS $0.23 vs. est. loss (-$0.04); Q3 sales $271.2M vs. est. $248.65M; said sales growth was driven by strong consumer response to new products and marketing; raises 2026 net sales outlook to $980M-$990M from $953.8M-$973.8M and expects 2026 adj operating margin between 5.5% and 6.5%;  announced a five-year extension of its global licensing agreement with Diesel.
• GoPro (GPRO) said it is unable to file Q3 form 10-Q for quarter ended sept 30, 2026 on time; requires additional time to complete q3 2026 financial close procedures.
• Grocery Outlet (GO) Q3 adj. EPS $0.16 vs. est. $0.15 (beat); sales $1.178B vs. est. $1.167B (beat); adj. EBITDA $59.4Mm vs. est. $60.8Mm (miss); gross profit $353Mm, gross margin 30%; sees FY26 sales $4.70B-$4.72B vs est $4.701B (in line), adj. EPS $0.52-$0.55 vs. est. $0.55 (below at midpoint), and adj. EBITDA $225Mm-$229Mm vs est $232.21Mm (below)
• StubHub (STUB) Q3 EPS $0.05 vs. est. $0.11; Q3 revs $502M vs. est. $507M; Q3 Gross Merchandise Sales of $2.62B, a $181.6M, or 7% increase compared to $2.43B y/y; backs FY26 adjusted EBITDA view $400M-$420M and boosts FY26 GMS view to $10.175B-$10.375B from $10.1B-$10.3B.
• Finland has approved Tesla's (TSLA) Assisted Driving system for immediate use after recognizing provisional type-approval granted by Dutch authorities, the country's transport regulator said

• Gevo (GEVO) Q3 adj EPS $0.12 vs. est. $0.02; Q3 revs $82.95M vs. est. $54.5M; said Q3 revenue included $29.4 mln from sales of Canadian Clean Fuel Regulation credits, most generated in prior period; raises FY26 adjusted EBITDA view to greater than $90M from $60M; expects 2026 adj EBITDA to exceed $90M and 2027 adj EBITDA to exceed $70M.
• Talen Energy (TLN) secures 750 MW long-term power capacity deal worth ~$100M annually; the 7 year agreement with an investment-grade counterparty covers PJM delivery years 2029/30 through 2035/36.

• Toast (TOST) downgraded to Market Perform from Outperform at Bernstein while cuts its price tgt to $38 from $45 saying that one of its biggest thesis points behind its February upgrade - Toast being an AI winner, not a loser - has already played out, and Bernstein is incrementally watching competition and cost of growth. The departure of the CFO is also not ideal as well.
• Western Union (WU) announced that it has delivered a notice of termination of its agreement to acquire Intermex (IMXI) after the companies failed to secure the approvals needed to complete the deal. Western Union said the final conditions of approval for the merger from California's Department of Financial Protection & Innovation (DFPI) were "unacceptable”.

• Neuronetics (STIM) 18.75M share Spot Secondary priced at $1.60
• PepGen (PEPG) announced the launch of a public offering of $125M of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock.
• Prime Medicine (PRME) 35.7M share Spot Secondary priced at $3.50

• Astronics Corp. (ATRO) Q3 sales $271.7Mm vs. est. $268Mm (beat), up 28% Y/Y; adj. EBITDA $59.3Mm vs est $53.54Mm (beat), margin 21.8%; adj. operating Income $51Mm, margin 18.8%; gross profit $94Mm, gross margin 34.6%; sees Q4 revenue $255Mm-$275Mm vs. est. $274.6Mm (below at midpoint); sees FY26 revenue $1.02B-$1.04B vs. est. $1.03B.
• Firefly Aerospace (FLY) Q3 revs $110.7M vs. est. $102.3M; guides FY26 revs $440M-$450M vs. est. $439.4M; posts record backlog of $1.7B.
• Mercury Systems (MRCY) Q1 adj. EPS $0.52 vs. est. $0.30 (beat); revenue $253.2Mm vs. est. $244.9Mm (beat); adj. EBITDA $56Mm vs. est. $39.1Mm (beat).
• Spire Global (SPIR) Q3 EPS ($0.52) vs est ($0.34); revenue $18Mm vs. est. $20.6Mm, up 42% Y/Y; gross profit $8.3Mm; operating loss $20.2Mm; sees FY26 revenue $75Mm-$80Mm vs. est. $80Mm (below at midpoint), narrowed from $75Mm-$85Mm, and adj. EBITDA loss $27.4Mm-$32.4Mm vs est loss $24.21Mm.

• Underwriters led by Goldman Sachs (GS) and Morgan Stanley (MS) are considering raising Anthropic's (ANT) proposed IPO price range following strong investor demand, the Financial Times reported. The initial $70-$78 range implied a fully diluted valuation of $1.26T-$1.41T, but revised pricing could push the target valuation to $1.5T or higher. https://tinyurl.com/444utux8
• OpenAI's quarterly revenue rose about 50% to $10 billion in the third quarter, but the ChatGPT maker continued to post steep operating losses, the Wall Street Journal reported. OpenAI told investors its adjusted operating margin improved to -109% from -150% in the prior quarter. The company's operating losses widened to $10.9 billion from $10.1 billion, the WSJ report said.
• Clearfield Inc. (CLFD) Q4 EPS $0.00 vs. est. $0.05 (miss); sales $39.3Mm vs. est. $40.4Mm (miss); gross profit $12.1Mm; sees FY27 EPS $0.25-$0.46 vs est $0.89 (below) and sales $195Mm-$205Mm vs. est. $187.1Mm.
• Evolv Technology (EVLV) Q3 adj. EPS ($0.02) vs. est. ($0.02) (in line); revenue $47.3Mm vs. est. $45.6Mm (beat), up 10% Y/Y; adj. EBITDA $4.7Mm vs est $3.363Mm (beat); ARR $140.5Mm, up 20% Y/Y; sees FY26 revenue $182Mm-$185Mm vs. est. $182.4Mm (in line), raised from $180Mm-$185Mm.
• Kopin Corp. (KOPN) Q3 EPS ($0.02) vs. est. ($0.01) (miss); revenue $18.2Mm vs. est. $16Mm (beat), up 52% Y/Y and 43% Q/Q, driven by funded development programs; operating loss $0.5Mm vs. $3.5Mm Q/Q; operating cash flow $2.4M; secured additional $18.6Mm IBAS award, bringing cumulative funding to $34M
• Rigetti Computing (RGTI) Q3 adj. EPS ($0.06) vs. est. ($0.05) (miss); revenue $1.41Mm vs. est. $3.52Mm (miss); operating loss $33.2Mm; gross profit $0.86Mm; cash, equivalents and investments $497.1Mm; sees FY26 revenue $20Mm vs. est. $22.9Mm (below).
• Sonos (SONO) Q4 adj. EPS $0.04 vs. est. $0.05 (miss); revenue $344.4Mm vs. est. $340.3Mm (beat), up 20% Y/Y; adj. EBITDA $6Mm; operating loss $10.7Mm; authorized $150Mm buyback, funded from existing cash or future cash flow.

Mid-Morning Look

Tuesday, November 10, 2026

U.S. stocks open lower as a “hotter-than-expected” consumer price index (CPI) this morning stoked inflation concerns and pushed market odds on a 25 bps Federal Reserve interest rate hike up to 86% and introduced a 14% chance of a half-point move. After U.S. stocks tumbled the worst in years last Thursday following a Democratic “Blue wave” midterm election win, taking back the House and the Senate, markets have recovered the last two days in a generally broad based rally. A lower close in stocks today post CPI data would mark a sharp break from back-to-back gains. Not helping today, bond yields rose (10-yr +12 bps back near 5%) on the CPI release along with a bounce in the dollar, pressuring precious metals. The Nasdaq 100 ETF (QQQ) fell below $670 this morning, down from $679.35 close after topping/but failing to hold its 200dma resistance yesterday of $681.20 as tech slides on rate fears/NVDA headlines which collide with Anthropic's (ANT) blockbuster IPO plans now set for next week. Anthropic's draft prospectus targets up to $64.4 billion from its public offering and $90.4 billion in total including a $26 billion private placement with cornerstone investors GOOGL, NVDA, AMD, MU, MSFT and TSM, pricing shares between $70 and $78 as the company targets a $1 trillion valuation. Oil prices extended losses from the previous session on Tuesday after US President Donald Trump downplayed the need for additional military action against Iran, easing fears of sustained Middle East supply disruptions, with prospects of oversupply also in focus. While stocks opened lower, major averages have bounced nicely off lows despite CPI data, with technology (XLK) and Financials (XLF) leading, though breadth is weak.

• Quantum sector: big day for earnings as three companies out with results: 1) QMCO rises as Q2 revs  rose 42.9% y/y to $89.63M vs. est. $82.3M; said strong secondary-storage demand, including major Scalar i7 Raptor and ActiveScale orders, helped lift revenue and backlog to nearly $100M; 2) QUBT shares dipped after Q3 EPS loss ($0.07) misses est. ($0.05), while revenue $9.5Mm vs. est. $7.21Mm (beat), compared with $0.384Mm Y/Y and $9.2Mm for H1 FY26; 3) QBTS posted a slight Q3 rev beat of $4.51M vs. est. $4.33M.
• Optical sector active after reports that MSFT is urging the Trump administration to abandon plans to ban Chinese optical transceivers, warning that supply disruptions could severely delay US AI infrastructure projects, Reuters reports. Microsoft currently has 35 US data centers under construction and another 134 planned, while China controls roughly 67% of the global optical transceiver market. COHR, LITE lack the production scale to replace Chinese suppliers.
• Software sector: ZETA delivered 29.7% organic ex-political revenue growth, with free cash flow up 73.0% y/y, outpacing total revenue growth, and raised full-year guidance across revenue, adjusted EBITDA, free cash flow, and earnings per share. TTWO reported Q2 bookings slightly below the low end of guidance and both ours/consensus estimates, as a softer NBA 2K27 launch offset GTA outperformance. FY27 bookings guidance was reiterated, however, management noted that GTA VI preorders are tracking "far in excess" of initial expectations. APPS shares tumbled a quarterly revenue of 178.7M and Adjusted EBITDA of $39.8M both easily beat the Street, and management raised the fiscal 2027 revenue guide by $20M at both ends, yet left Adj EBITDA guidance exactly where it sat last quarter, at $145M to $155M.

• PEPG +158%; as announces positive phase 2 FREEDOM2-DM1 10 mg/kg results demonstrating highest reported splicing correction and improvements across multiple functional measures.
• PXLW +25%; as announced a new multi-year partnership and device certification agreement with META, including Meta's VR devices, including the upcoming Meta VR Glasses.
• SANM +6%; as Q4 EPS $4.43, easily topping est of $3.27 and revs of $3.86B topped ests $3.48B saying results reflected broad-based demand, benefits from ZT Systems integration that bolstered SANM's cloud and AI infrastructure business; sees FY27 EPS $15.50-$17.50, above est of $14.07.
• TTWO +4%; reported Q2 bookings slightly below the low end of guidance and both ours/consensus estimates, as a softer NBA 2K27 launch offset GTA outperformance. FY27 bookings guidance was reiterated, however, management noted that GTA VI preorders are tracking "far in excess" of initial expectations

• GSHD -14%; reported prelim Q3 results instead of full due to pending restatements due to a SEC comment letter. Both total revenue and the bottom line result were better than we expected, but core revenues grew less quickly than hoped.
• HIMS -12%; mixed Q3 results, in which revs and adj. EBITDA came in below consensus as a pullback in marketing spend, as well as a deferral of weight loss revenues proved to be the culprit of the weaker than expected quarter for HIMS, translating into a seq. decline in subscriber count.
• NVDA -3%; after President Trump said last night that the FBI is investigating CEO Jensen Huang's affair with a suspected Chinese spy. Wells Fargo acknowledged the "key man" risk that the Huang ordeal poses to Nvidia, given the CEO's importance to the company.
• QLYS -8%; posted top and bottom line beats for Q3 as well as adj. EBITDA $89.9Mm and adj. operating Income $87.1Mm above views; QLYS raised its FY26 guidance across the board but was overshadowed by the significant slowdown in Q4 billings q/q.
• SKYD -8%; reported Q3 results and said it plans to slash at least $6 billion in annual costs following its combination of Paramount and Warner Bros. Discovery; Q3 revs rose 5% y/y to $7.03B vs. est. $7.04B and TV Media revenue slid 7% due to a decline in advertising sales.

Closing Recap

Tuesday, November 10, 2026

U.S. stocks gave back a small portion of the prior day gains, as a further pullback in shares of AI poster child NVDA (-5.53% today after -4.27% Monday) amid its ongoing CEO drama dragged shares near 52-week lows and took the AI supply chain lower in sympathy. Meanwhile, an increase in consumer prices (CPI) inflation in October pushed Treasury yields sharply higher, raising the prospect of potential aggressive rate hikes by the Fed at the December meeting. NVDA shares tumbled a second day after founder and CEO Jensen Huang announced his extramarital affair this weekend, which allegedly was with a possible spy for China, raising all sorts of concerns, and potentially putting the entire industry at risk due to NVDA’s close relationship with so many AI companies. The CEO's relationship with Alice Huang facilitated the shipment of at least $7.5 billion worth of the company's chips through Chinese firms, The Information reported.

Outside of the continued fallout from the NVDA scandal the last 2 days, Anthropic IPO day will be Thursday, November 19 after the company formally filed its updated S1 this morning. The IPO details showed they will sell ~825M in total shares during the upcoming offering, including ~800MM from the company itself and ~24MM from existing investors, for a total of ~$61B (vs. $70-78 indicated range). In addition, the company aims to take in an additional ~$26B by selling stock to cornerstone investors (such as AMD, Broadcom, Google, Nvidia, Micron, Microsoft, TSMC, etc.), which means the total raised would be ~$85-90B (the market had been assuming ~$90B, so this is approximately inline). Another story that didn’t get as much play was SoftBank Group disclosing a $3.7 billion charge tied to power equipment procurement, that weighed heavily on power names like BE, GEV and others. JP Morgan noted the news is a negative, as it marks a major Datacenter developer re-thinking its plans for power Equipment.

Higher Treasury yields also hurt markets: Along with technology weakness, the surge in yields really following the CPI data put a damper on interest rates sensitive stocks and asset classes as precious metal prices tumbled along with crypto assets as Bitcoin dropped over 2%. The 10-yr yield rose over 14 bps topping 5% while the shorter term 2-yr yield, which is more impacted to near term rate moves, rose over 20bps early after U.S. consumer prices increased more than expected in October, rising 0.4% from the previous month. Homebuilders such as DHI, KBH, MTH, PHM, LEN all tumbled as well as mortgage related companies as the sharply higher move in Treasury yields on CPI/rate hike fears hit interest rate sensitive sectors. Dallas Fed President Lorie Logan said today that the Fed may need to pick up the pace of interest-rate increases after a report showed inflation was firmer than expected in October.

• NY Fed reported Q3 total household debt climbs $334B to $19.1 trillion, while Q3 mortgage debt climbs $257B to $13.4 trillion, overall Q3 delinquency rate climbed relative to Q2 and Q3 credit card debt climbs $22B to $1.3 trillion.  Q3 overall flow into “serious” delinquency down from Q3 2025. Q3 share of student loans 90 days or more past due little changed at 10.9%

• The U.S. gas price average finally fell below $4 today, according to AAA as the U.S. average gas price today $3.97; the lowest price since July 16 and the first time below $4 since July 19.
• @FreightWaves noted on X, “The benchmark diesel price used for most fuel surcharges fell 16.5 cents per gallon to $6.127, according to the Department of Energy/EIA average weekly retail price. It is the second straight weekly decline and the lowest level since Oct. 12.
• US crude production is expected to hit a record high for the fourth straight year in 2026, at 13.9 million barrels per day, the Energy Information Administration said on Tuesday. In 2025, output was 13.7 million bpd. US crude output is then set to rise again in 2027, to 14.3 million bpd.
• December gold tumbled -$84.30, or -2.05%, to settle at $4,030.20 an ounce while December silver declined -$1.47, or -2.79%, to finish the day at $51.23 an ounce, pressured by a bounce in the dollar and a spike in Treasury yields following the October CPI data.

• Auto sector: TM raised its annual profit forecast by 20% as now sees full-year operating profit forecast to 780 billion yen ($4.94 billion) from 650 billion yen, as it expected robust demand for hybrid vehicles and a boost from a weaker yen to help offset slumping sales in China. Operating profit for the July-to-September quarter fell 39% from a year earlier to 118 billion yen, well below the 250 billion yen median forecast.
• Lodging & Leisure: online travel stocks have benefited from a roll in oil over the past week, but shares of BKNG, EXPE, ABNB, TRIP rolled slightly this afternoon after a report in The Information said OpenAI acquires Ai Travel Agent Odessia. The news was confirmed by Odessia CEO saying in a post on X, formerly Twitter, "I'm thrilled to announce that Odessia was acquired by OpenAI, and that I will be joining the team to focus on the future of travel.

• Insurance sector: GSHD reported prelim Q3 results instead of full due to pending restatements due to a SEC comment letter. Both total revenue and the bottom line result were better than we expected, but core revenues grew less quickly than hoped driven (in part) as bigger than expected price policy price declines in Texas were offset less than hoped by improving customer retention

• HIMS reported mixed Q3 results, in which revs and adj. EBITDA came in below consensus as a pullback in marketing spend, as well as a deferral of weight loss revenues proved to be the culprit of the weaker than expected quarter for HIMS, translating into a seq. decline in subscriber count.
• JNJ announced that a second late-stage pivotal trial for its atypical antipsychotic Caplyta met its primary and key secondary endpoints in adults with manic episodes associated with bipolar I disorder. The once-daily therapy is already approved in the U.S. for adults with bipolar I or II disorder and major depressive disorder as monotherapy or as adjunctive therapy.
• PEPG announces positive phase 2 FREEDOM2-DM1 10 mg/kg results demonstrating highest reported splicing correction and improvements across multiple functional measures.
• SRPT was upgraded to Hold from Sell at Deutsche Bank and raise tgt to $18 from $14 after Q3 results saying they are more confident that a large downside move in the shares over the next term is unlikely. Sarepta's setup into 2027 "looks decent" on potential for improved fundamentals.

• Industrial sector: AAON reported 3Q26 adj. EPS of $0.83, ahead of $0.56 consensus, driven by significantly higher sales (up ~+84% y/y) and margins (GPM of 26.7%), particularly in ACP. Although BASX backlog again declined q/q (down ~-5%; albeit up ~+51% y/y); GFL shares fell after the Canadian waste management firm said it rejected buyout proposals and will stay public. The Board is unanimous in its conviction that GFL's standalone growth plans offer far superior risk-adjusted returns for shareholders," the chair of the board’s special committee, said.
• Aerospace sector: aircraft parts maker TDG reported a Q4 top and bottom line beat ($12.44/$2.99B in revs vs. est. $12.32/$2.95B), but forecasts FY27 adjusted EPS of $47.09-$47.94, which was below the Street est of $49.17, but better sales of $11.95B-$12.15B vs. est. $11.8B. RKLB reported record Q3 revs of $268M (up 73% Y/Y), beating ests $258M, while GAAP EPS loss of ($0.12) was wider than ests at (-$0.07), partly reflecting a $27M loss on debt extinguishment. GAAP operating cash flow turned positive at $7.2M, and backlog hit a record $3.57B (52% Q/Q).
• Satellite sector: VSAT said it has been awarded an indefinite delivery/indefinite quantity contract with a ceiling of $450M by the U.S. Space Force's Space Systems Command. ASTS reported revenue of $42.3M, up 34% sequentially and an EBITDA loss of -$91.2M versus 79.5M estimate.

• SoftBank (SFTBY) swung to a $7B net loss in July-September, missing every analyst forecast. The loss included a $3.7B charge on advance payments for power equipment after it revised procurement plans for its US AI data centers. Financing costs also more than doubled, while SoftBank raised $5B in September by expanding a margin loan backed by its Arm shares. The 1.1 trillion yen ($7 billion) second-quarter net loss far exceeded analysts' forecasts and compares with a 2.5 trillion yen profit in the same period a year earlier.
• Nscale, a British cloud provider backed by chip giant Nvidia, is considering delaying a $35 billion stock market listing, the Telegraph reported on Tuesday. Executives at the data centre developer are assessing whether to pause efforts to go public until next year, the report added.
• HIVE reported a $78.7M quarterly net loss, as mining revenue fell 7.4% to $76M. Its Ai Computing revenue rose 70.7% to $8.8M, with contracted GPU Cloud annualized revenue reaching $185M.
• MARA Q3 EPS $1.28 vs. est. ($0.10) (beat), driven by an $885.3Mm unrealized Bitcoin mark-to-market gain vs. $343.1Mm Y/Y; revenue $164.2Mm vs. est. $176.1Mm (miss), down 34.9% Y/Y, as a 37% drop in the average price of Bitcoin mined reduced revenue $94.8Mm.
• RIOT was upgraded from Hold to Buy and raise tgt to $28 from $13 saying on its own, with no value after the lease ends, Corsicana is worth about $16 per share at a 10% discount rate. That is close to the ~$17 share price, before counting Rockdale or AMD. Catalysts are credit support at Rockdale, the Corsicana financing in 2027, and first Rent in September 2027.

• EMS Sector: SANM shares jumped on earnings results as the manufacturing solutions firm posted Q4 EPS $4.43, easily topping consensus est of $3.27 and revs of $3.86B topped ests $3.48B saying results reflected broad-based demand, benefits from ZT Systems integration that bolstered SANM's cloud and AI infrastructure business; sees FY27 EPS $15.50-$17.50, above est of $14.07.
• Security software sector: QLYS posted top and bottom line beats for Q3 as well as adj. EBITDA $89.9Mm and adj. operating Income $87.1Mm above views; QLYS raised its FY26 guidance across the board but was overshadowed by the significant slowdown in Q4 billings q/q.
• Optical sector active after reports that MSFT is urging the Trump administration to abandon plans to ban Chinese optical transceivers, warning that supply disruptions could severely delay US AI infrastructure projects, Reuters reports. Microsoft currently has 35 US data centers under construction and another 134 planned, while China controls roughly 67% of the global optical transceiver market. COHR, LITE lack the production scale to replace Chinese suppliers.
• Quantum sector: big day for earnings as three companies out with results: 1) QMCO rises as Q2 revs  rose 42.9% y/y to $89.63M vs. est. $82.3M; said strong secondary-storage demand, including major Scalar i7 Raptor and ActiveScale orders, helped lift revenue and backlog to nearly $100M; 2) QUBT shares dipped after Q3 EPS loss ($0.07) misses est. ($0.05), while revenue $9.5Mm vs. est. $7.21Mm (beat), compared with $0.384Mm Y/Y and $9.2Mm for H1 FY26; 3) QBTS posted a slight Q3 rev beat of $4.51M vs. est. $4.33M.
• Software sector: ZETA delivered 29.7% organic ex-political revenue growth, with free cash flow up 73.0% y/y, outpacing total revenue growth, and raised full-year guidance across revenue, adjusted EBITDA, free cash flow, and earnings per share. TTWO reported Q2 bookings slightly below the low end of guidance and both ours/consensus estimates, as a softer NBA 2K27 launch offset GTA outperformance. FY27 bookings guidance was reiterated, however, management noted that GTA VI preorders are tracking "far in excess" of initial expectations. APPS shares tumbled a quarterly revenue of 178.7M and Adjusted EBITDA of $39.8M both easily beat the Street, and management raised the fiscal 2027 revenue guide by $20M at both ends, yet left Adj EBITDA guidance exactly where it sat last quarter, at $145M to $155M.

• Semi equipment sector: ENTG authorizes $500M share repurchase authorization, 10% dividend increase, and provides long term outlook at CMD; ONTO beat revenue and guidance expectations, with strong growth amid accelerating WFE demand supporting expectations for continued market outperformance through 2028 and significant gross and operating margin expansion; posted Q3 adj. EPS $2.44 vs. est. $2.30 (beat); record revenue $409.7Mm vs. est. $392Mm (beat).
• Ad Tech sector: results for both TTD and PUBM solid but shares fell as results potentially skewed by political spending; PUBM 3Q revenue +17% y/y vs. 2Q +11%, but included ~6 points of political spend, with guide 1% above Street, +15% y/y, a 2% deceleration on a 2-year basis; TTD reported better Q3 results/Q4 guide, partially driven by one-time benefit and stronger political spending
• Media sector: SKYD reported Q3 results and said it plans to slash at least $6 billion in annual costs following its combination of Paramount and Warner Bros. Discovery; Q3 revs rose 5% y/y to $7.03B vs. est. $7.04B and TV Media revenue slid 7% due to a decline in advertising sales; Q3 direct-to-consumer revenue rose 11% in the quarter, reflecting 6% subscriber growth.
• Internet sector: WIX was double downgraded to Underperform from Buy at Bank America and lowers revenue growth to 12% from 14%, and lower EBITDA margin to 15% from 18% citing core deceleration, especially in the Partners segment.

Street Recommendations

Wednesday, November 11, 2026

• CWST Barclays raised the firm's price target on Casella Waste to $109 from $104 and keeps an Overweight rating on the shares post the Q3 report. The company's Mid-Atlantic initiatives are taking hold and its new multiyear targets provide visibility, the analyst tells investors in a research note.
• LGND Barclays analyst Glen Santangelo raised the firm's price target on Ligand to $350 from $345 and keeps an Overweight rating on the shares. The share setup post the Q3 report "looks good" as the implied Q4 guidance midpoint is beatable bar, the analyst tells investors in a research note.
• ONON Barclays analyst Adrienne Yih lowered the firm's price target on On Holding to $42 from $44 and keeps an Overweight rating on the shares post the Q3 report. On's sales matched estimates as it held to full-price selling in a promotional footwear backdrop, the analyst tells investors in a research note.
• WCC Barclays analyst Guy Hardwick raised the firm's price target on Wesco to $450 from $437 and keeps an Overweight rating on the shares. The company provides exposure to grid investment and data centers, the analyst tells investors in a research note. Barclays tells investors to stop worrying about Wesco's cash flow.
• XERS Barclays raised the firm's price target on Xeris Biopharma to $18 from $14 and keeps an Overweight rating on the shares. The company's "impressive" Q3 was driven by Recorlev, which is outperforming on the back of Cushing's market strength and Xeris' commercial efforts, the analyst tells investors in a research note.

• FIS Bernstein analyst Harshita Rawat lowered the firm's price target on FIS to $31 from $48 and keeps a Market Perform rating on the shares. Since early June, the average performance across the firm's coverage of Payments, Processors & IT Services names has been up 10% vs. market down 1%. Bernstein sees further upside potential given still high free cash flow yield, potential for meaningful shareholder returns, and strategic unlocks across the sector.
• FISV Bernstein raised the firm's price target on Fiserv to $70 from $60 and keeps a Market Perform rating on the shares. Since early June, the average performance across the firm's coverage of Payments, Processors & IT Services names has been up 10% vs. market down 1%. Bernstein sees further upside potential given still high free cash flow yield, potential for meaningful shareholder returns, and strategic unlocks across the sector.
• GPN Bernstein analyst Harshita Rawat raised the firm's price target on Global Payments to $100 from $86 and keeps a Market Perform rating on the shares. Since early June, the average performance across the firm's coverage of Payments, Processors & IT Services names has been up 10% vs. market down 1%. Bernstein sees further upside potential given still high free cash flow yield, potential for meaningful shareholder returns, and strategic unlocks across the sector.
• MA Bernstein raised the firm's price target on MasterCard to $764 from $730 and keeps an Outperform rating on the shares. Since early June, the average performance across the firm's coverage of Payments, Processors & IT Services names has been up 10% vs. market down 1%. Bernstein sees further upside potential given still high free cash flow yield, potential for meaningful shareholder returns, and strategic unlocks across the sector.
• PYPL Bernstein analyst Harshita Rawat raised the firm's price target on PayPal to $60 from $55 and keeps a Market Perform rating on the shares. Since early June, the average performance across the firm's coverage of Payments, Processors & IT Services names has been up 10% vs. market down 1%. Bernstein sees further upside potential given still high free cash flow yield, potential for meaningful shareholder returns, and strategic unlocks across the sector.
• V Bernstein raised the firm's price target on Visa to $486 from $475 and keeps an Outperform rating on the shares. Since early June, the average performance across the firm's coverage of Payments, Processors & IT Services names has been up 10% vs. market down 1%. Bernstein sees further upside potential given still high free cash flow yield, potential for meaningful shareholder returns, and strategic unlocks across the sector.

• BJ BofA analyst Christopher Nardone raised the firm's price target on BJ's Wholesale to $116 from $106 and keeps a Neutral rating on the shares. The firm, which sees potential upside to its Q3 comp ex-gas forecast of 2.5% given support from traffic driving initiatives during the quarter, cites increased EPS estimates and a rerating in peer multiples for its higher target.
• LQDA BofA raised the firm's price target on Liquidia to $54 from $42 and keeps a Neutral rating on the shares after the company reported Q3 Yutrepia sales in line with the preliminary figure disclosed alongside the litigation settlement and provided incremental color on the durability of Yutrepia growth. The firm looks for further evidence on Yutrepia's PAH growth trajectory and the durability of the existing PH-ILD patient base following the settlement, the analyst tells investors.
• SE BofA lowered the firm's price target on Sea Limited to $110 from $130 and keeps a Buy rating on the shares. Sea reported "robust" 43% top-line growth, coming in ahead of BofA and Street estimates, but adjusted EBITDA was lower than expectations, mainly due to a miss on Monee margins, the analyst tells investors.
• STLA BofA lowered the firm's price target on Stellantis to EUR 3.50 from EUR 5.50 and keeps an Underperform rating on the shares, primarily reflecting a weaker 2027 cash-flow outlook. 2027 "remains the key concern," says the analyst, who forecasts adjusted operating income declining slightly to EUR 2.2B, or a 1.4% margin, "well below" consensus at EUR 3.9B and 2.4%, respectively.

• WIX Cantor Fitzgerald lowered the firm's price target on Wix.com to $80 from $90 and keeps an Overweight rating on the shares. Wix.com's revenue beat was offset by weaker operating income and lower free cash flow guidance due to B44 marketing investment, while healthy annual recurring revenue growth, improving retention and product traction support the longer-term outlook, the analyst tells investors in a research note.
• SATL Cantor Fitzgerald lowered the firm's price target on Satellogic to $7 from $9 and keeps an Overweight rating on the shares. Satellogic successfully launched its first Merlin satellite on schedule and within budget, with two additional launches planned for 1H27 and initial revenues targeted for 2H27, the analyst tells investors in a research note.
• VELO Cantor Fitzgerald analyst Troy Jensen lowered the firm's price target on Velo3D to $12 from $17 and keeps an Overweight rating on the shares. Velo3D beat Q3 revenue expectations, with bookings exceeding sales and $40.1M in backlog, but higher investment spending and a delay in positive adjusted EBITDA to 2028 temper the outlook, the analyst tells investors in a research note.
• NRGV Cantor Fitzgerald analyst Derek Soderberg raised the firm's price target on Energy Vault to $12 from $7 and keeps an Overweight rating on the shares. Energy Vault delivered in-line Q3 revenue and reaffirmed 2026 guidance, while introducing strong 2027 revenue and EBITDA targets, the analyst tells investors in a research note.
• NAMS Cantor Fitzgerald analyst Steve Seedhouse raised the firm's price target on NewAmsterdam Pharma to $61 from $52 and keeps an Overweight rating on the shares. The firm's contrarian outlook reflects an increase in PREVAIL's probability of success from 65% to 75%, with the 1Q27 interim analysis offering asymmetric upside given obicetrapib's novel mechanism and the potential for final trial success even if the interim analysis is not positive, the analyst tells investors in a research note.

• ZYME Citi raised the firm's price target on Zymeworks to $44 from $39 and keeps a Buy rating on the shares. The company upped its 2026 revenue guidance to reflect contribution from the recent Roche collaboration, the analyst tells investors in a research note. Citi says Zymeworks' progress in diversifying the business is gaining momentum.

• TER Jefferies analyst Dushyant Ailani initiated coverage of Teradyne with a Buy rating and $284 price target. Teradyne has shifted from a mobile-led tester into an AI compute play, the analyst tells investors. The firm's FY27 and FY28 revenue estimates of $6.7B and $8.5B are about 2% and 5%, respectively, above consensus, the analyst noted.
• BDC Jefferies initiated coverage of Belden with a Hold rating and $114 price target. With Ruckus adding wireless and AI data centers a new growth avenue, Belden is becoming a broader networking platform and the firm likes the direction, but the near-term case rests on Ruckus supply constraints and cross-selling, a data center ramp concentrated in one customer, and deleveraging, the analyst tells investors.
• LFUS Jefferies analyst Dushyant Ailani initiated coverage of Littelfuse with a Buy rating and $471 price target. Littelfuse has historically been viewed as a circuit protection supplier levered to cyclical industrial and transportation markets, but management is repositioning the portfolio toward high growth opportunities, the analyst noted. The firm is constructive on the company's pivot to data center, grid/utility and A&D, which it estimates reach about 25% of revenue by FY30, up from 10%-15% today.
• ZBRA Jefferies analyst Dushyant Ailani initiated coverage of Zebra Technologies with a Buy rating and $382 price target. The stock is down about 10% since Q3 as the market extrapolates memory-driven margin pressure beyond the 21.6% adjusted EBITDA margin, but the firm sees about 22% as "defensible" and models about 8% topline growth in FY27, the analyst tells investors.
• CGNX Jefferies initiated coverage of Cognex with a Buy rating and $64 price target. With shares off about 31% from their June highs on Q2 margin caution, RealSense dilution concerns and the broader semi and AI-hardware selloff, the sees "an entry point," the analyst tells investors.
• GLW Jefferies initiated coverage of Corning with a Buy rating and $134 price target. Corning sits at the center of an AI-driven fiber shortage, with multi-year hyperscaler and carrier contracts underpinning growth, the analyst tells investors.
• FORM Jefferies analyst Dushyant Ailani initiated coverage of FormFactor with a Buy rating and $102 price target. Shares are about 47% off June highs, notes the analyst, who sees the pullback as an entry point. The firm's FY27 EPS estimate is about 5% above consensus, the analyst tells investors.
• ST Jefferies initiated coverage of Sensata with a Hold rating and $40 price target. Sensata is redeploying Auto/EV sensing and electrical-protection tech into data centers and and aerospace, defense, and commercial equipment, but the firm estimates auto still will make up about 51% of revenue in FY28, versus about 55% today.

• ETN JPMorgan resumed coverage of Eaton with a Neutral rating and $395 price target. The firm is not "brimming with enthusiasm" on the electrical equipment and multi-industry sector. However, it does expect a bounce in the AI-linked stocks given the magnitude and longevity of the recent selloff. JPMorgan favors names with a relatively high degree of earnings visibility.
• JCI JPMorgan resumed coverage of Johnson Controls with a Neutral rating and $160 price target. The firm is not "brimming with enthusiasm" on the electrical equipment and multi-industry sector. However, it does expect a bounce in the AI-linked stocks given the magnitude and longevity of the recent selloff. JPMorgan favors names with a relatively high degree of earnings visibility.
• VRT JPMorgan analyst Julian Mitchell resumed coverage of Vertiv with a Neutral rating and $240 price target. The firm is not "brimming with enthusiasm" on the electrical equipment and multi-industry sector. However, it does expect a bounce in the AI-linked stocks given the magnitude and longevity of the recent selloff. JPMorgan favors names with a relatively high degree of earnings visibility.
• MRCY JPMorgan upgraded Mercury Systems to Overweight from Neutral with a price target of $102, down from $110. The firm views the Q3 report as a "proof point" for Mercury, saying the company delivered on its adjusted EBITDA margin target. Mercury's strong bookings increased its backlog, providing visibility into double-digit sales growth, the analyst tells investors in a research note. JPMorgan also believes the company's net leverage provides flexibility for cash deployment. It says Mercury is benefiting from strong demand. According to TipRanks, JPMorgan has a 5-star analyst on Mercury Systems.
• PHR JPMorgan analyst Destiny Jackson downgraded Phreesia to Underweight from Neutral with a price target of $13, down from $14, following a transfer of coverage. Phreesia's strategy has "continued to evolve and is difficult to follow with limited confidence in the path forward," the analyst tells investors in a research note. The firm believes the company's revenue growth is "structurally slowing" and screens at the low end of the peer group. The stock's risk/reward is less compelling without a clear timeline or catalyst for growth to reaccelerate, contends JPMorgan.
• GFL JPMorgan lowered the firm's price target on GFL Environmental to $40 from $42 and keeps an Underweight rating on the shares. The company's board rejected all bids to take GFL private, one of which was for $52 per share by a private equity consortium, the analyst tells investors in a research note. JPMorgan believes the shares deserve a lower valuation relative to peers given its "much higher leverage and much lower EBITDA margins."

• HUT Keefe Bruyette lowered the firm's price target on Hut 8 to $81 from $92 and keeps an Outperform rating on the shares. Beacon Point Phase 2 is valued at a 75% probability of approval, reflecting confidence in eventual permitting but increased uncertainty around the timing of TCEQ groundwater permit issuance, the analyst tells investors in a research note.

• NFG KeyBanc analyst Tim Rezvan lowered the firm's price target on National Fuel to $91 from $95 and keeps an Overweight rating on the shares. The firm cites updated modeling assumptions for 2027-2028. A poor year of FY26 Upstream execution is behind management, but challenges on development forecasting, along with a weak natural gas macro backdrop, lead KeyBanc to revisit assumptions.
• ONON KeyBanc raised the firm's price target on On Holding to $42 from $37 and keeps an Overweight rating on the shares. The firm notes Q3 slightly beat estimates, mostly on wholesale timing, while direct-to-consumer fell short of expectations. Looking at FY27, KeyBanc's view is that running innovation, apparel, and new sports support investor day goals of high-teens growth and continued EBITDA margin expansion.

• MD Mizuho analyst Ann Hynes downgraded Pediatrix Medical to Underperform from Neutral with an unchanged price target of $28. The firm believes the company's pricing gains "have largely plateaued," limiting potential for earnings upside going forward. Furthermore, Pediatrix remains highly exposed to the birth rate, which is outside the company's control, the analyst tells investors in a research note. Given the current inflationary backdrop and the expectations for low birth rates, Mizuho sees limited potential for meaningful recovery in Pediatrix 's volumes relative to other providers that are more diversified.
• G Mizuho raised the firm's price target on Genpact to $44 from $39 and keeps a Neutral rating on the shares. The firm views the company's Q3 report as strong. Genpact raised its 2026 gross margin outlook but held its adjusted operating margin guide at 17.7% for the year as it continues to invest to drive agentic operations growth, the analyst tells investors in a research note.
• COST Mizuho raised the firm's price target on Costco to $1,100 from $1,065 and keeps an Outperform rating on the shares. The company announced its "long-anticipated" special dividend payment of $30 per share payable in early December, the analyst tells investors in a research note. The firm says the amount is significantly above the $18-$20 per share it had forecast and represents a yield of 2.8% incremental to Costco's regular quarterly dividend.

• FDS Morgan Stanley raised the firm's price target on FactSet to $321 from $300 and keeps an Equal Weight rating on the shares. The firm raised its FY28 and FY29 margin expansion estimates after recently having attended FactSet's investor day, where management updated its medium-term financial framework.
• HALO Morgan Stanley downgraded Halozyme to Equal Weight from Overweight with a price target of $109, up from $105, citing valuation. Halozyme remains "one of the highest-quality royalty compounders" the analyst covers, but the next leg of value creation rests on Halozyme extending growth beyond royalty-rate step-downs, a new ADC opportunity and the next wave of Enhanze launches, says the analyst. While the firm continues to "like the story," it "would now enjoy it from the sidelines" with the stock having rallied 53% year-to-date.

• REZI Oppenheimer lowered the firm's price target on Resideo to $25 from $27 and keeps an Outperform rating on the shares following quarterly results. The firm notes that the Q4 revenue midpoint implies a 4% year-over-year decline. Core revenue should be flat to up low single digit year-over-year.

• DRTS Piper Sandler upgraded Alpha Tau to Overweight from Neutral with a $22 price target. The firm view Alpha DaRT as a differentiated technology with potential across multiple solid tumors, adding that the next 12 months are "an important catalyst period."

• CAC Stephens analyst Matt Breese raised the firm's price target on Camden National to $59 from $58 and keeps an Equal Weight rating on the shares. The firm thought Q3 results were "mostly positive," the analyst tells investors.
• IRTC Stephens lowered the firm's price target on iRhythm to $120 from $160 and keeps an Overweight rating on the shares. Shares are more than 30% lower since the Q3 print as a result of lowered organic growth expectations and likely lower investor confidence in iRhythm's MCT strategy, the analyst noted.

• PAA Wells Fargo analyst Praneeth Satish raised the firm's price target on Plains All American to $25 from $23 and keeps an Equal Weight rating on the shares. The firm cites a shift forward in the base year of its valuation models. Wells stays on the sidelines on valuation, but notes positive momentum into 2027 and potential for 2027 guide to exceed consensus estimates.
• PAGP Wells Fargo raised the firm's price target on Plains GP Holdings to $25 from $23 and keeps an Equal Weight rating on the shares. The firm cites a shift forward in the base year of its valuation models. Wells stays on the sidelines on valuation, but notes positive momentum into 2027 and potential for 2027 guide to exceed consensus estimates.
• WIX Wells Fargo analyst Alec Brondolo lowered the firm's price target on Wix.com to $63 from $64 and keeps an Equal Weight rating on the shares. The firm notes FY26 free cash flow margin guide was reduced 2pts and commentary suggests heavy Base44 investment continues in 2027. Investments don't appear congruous with pace of bookings growth, which likely decelerates in Q4, Wells adds.
• GO Wells Fargo analyst Edward Kelly raised the firm's price target on Grocery Outlet to $13 from $11 and keeps an Equal Weight rating on the shares. The firm says top line progress was offset by cost headwinds. Wells is disappointed to temper its 2027 bull case on earnings. Top-Line matters, but so does the rest of the P&L, it adds.
• VEEV Wells Fargo analyst Stan Berenshteyn raised the firm's price target on Veeva to $400 from $330 and keeps an Overweight rating on the shares. The firm sees $1B AI ARR by 2030 beyond Veeva's $6B core plan, requiring just 10% of its $10B AI TAM vs. core penetration doubling to roughly 30% of a $20B TAM by 2030. Checks point to compelling return on investment, supporting conviction in strong adoption, Wells adds.
• TTD Wells Fargo raised the firm's price target on Trade Desk to $15 from $12 and keeps an Equal Weight rating on the shares. The firm notes the company reported Q3 revenue 13% ahead of consensus, but excluding political advertising and one time revenue from a strategic partner, revenue declined 8% from a year earlier, compared with 3% growth in Q2. Q4 guide implies continued revenue decline. Tough to see a turn until take-rate reduced, Wells adds.
• LQDA Wells Fargo raised the firm's price target on Liquidia to $40 from $33 and keeps an Equal Weight rating on the shares. The firm found commentary on October demand encouraging, with less new patient demand less, but not by much. Wells expects some growth in Q4, but still believes there's uncertainty in the demand curve for Yutrepia.
• OXY Wells Fargo analyst Sam Margolin lowered the firm's price target on Occidental to $76 from $82 and keeps an Overweight rating on the shares. The firm notes the company continues to be characterized by business transformation into the 2030s toward higher structural free cash flow and return of capital optionality.

Rating abbreviations…

***OP = Outperform

***SP = Sector Perform

***UP = Underperform

***OW = Overweight

***EW = Equal-weight

***UW = Underweight

***Report powered by thefly.com***

What’s on Tap Weekly Calendar

• 10:00 AM ET                 Wholesale inventory M/M for September
• 1:00 PM ET US Treasury to sell $58B in 3-year notes

• Earnings After the Close: AAON ACHR AMCX AMRC APEI APPS ASTS BETR BKKT BTGO BW CCAP CHRS CNNE CSQR CWEN CWST DFTX DHT DJT DSP ETD FWRD GAIN GRPN GSHD HIMS HIVE HPK HRB HROW IHRT JRVR KLTR KMPR LCID LINE MARA MYO NRDY ONTO OSUR OXY PAYS PLUG PUBM QLYS QMCO QUBT RKLB RNGR RPAY RXT SANM SB SIGA SKYD TDW TTD TTWO USAR XENE ZETA ZIP ZYME

• Raymond James 2026 Insurance Conference, 11/9 (virtual)
• Oppenheimer 10th Annual Virtual Internet Bus Tour, 11/9-11/10 (virtual)
• China PPI, CPI, Import/Export data for October
• Wells Fargo EEI Financial Conference, 11/8-11/10, in Arizona

• 7:45 AM ET ICSC Weekly Retail Sales
• 8:30 AM ET                   Consumer Price index (CPI) headline M/M for October
• 8:30 AM ET                   Consumer Price index (CPI) headline Y/y for October
• 8:30 AM ET CPI core – Ex: Food & Energy M/M for October
•  8:30 AM ET CPI core – Ex: Food & Energy Y/Y for October
• 8:55 AM ET                   Johnson/Redbook Weekly Sales
• 10:00 AM ET                 Cleveland Fed CPI for October
• 1:00 PM ET US Treasury to sell $39B in 10-year notes
• 4:30 PM ET API Weekly Inventory Data

• Earnings After the Close: AIRG AMPX ANGX ATEX ATRO BEEP BGS BODI BRCB BV CAPR CLFD CRWV EC ELMD EVLV FLY FOSL GENK GEVO GO GRWG HYLN INO KOPN KURA LAND LMRI LPTH MCHX MRCY NCMI NLST PBR PETS QUIK REZI RGTI SKYH SONO SPIR STUB STXS TELO VIV

• Oppenheimer 10th Annual Virtual Internet Bus Tour, 11/9-11/10 (virtual)
• Raymond James 2026 Texas Bank Symposium, 11/10-11/12, in Dallas, TX
• Wells Fargo EEI Financial Conference, 11/8-11/10, in Arizona

• Earnings After the Close: AGBK AGRO ALVO AVEX CAE CINT CTVA DDI DGII ENS FNV ITRG OPRX PXLW TK TNK XAIR

• Stifel Healthcare Conference, 11/11-11/13, in New York

• 8:30 AM ET                   Continuing Claims
• 10:00 AM ET                 Existing Home Sales M/M for October
• 12:00 PM ET                 Weekly EIA Inventory Data (pushed out a day for Veteran’s Day)
• 1:00 PM ET US Treasury to sell $22B in 30-year notes
• 2:00 PM ET                    Federal Budget for October

• Earnings After the Close: AENT AFYA AMAT ARWR AVX BEAT CBRS CDXS CODX CSCO CTSO DLO DMRC FLNT FLO GEMI HAWK HTFL JCAP KLC LFTO MDXH NKTR NMAX SPCE NU OFRM PAL PARK SPCE STN STNE VRCA VUZI WHK WYY XOS YSS

• Stifel Healthcare Conference, 11/11-11/13, in New York
• Truist Securities BioPharma Symposium, 11/12, in New York

• 8:30 AM ET                   Producer Price index (PPI) headline Y/y for October
• 8:30 AM ET PPI core – Ex: Food & Energy M/M for October
•  8:30 AM ET PPI core – Ex: Food & Energy Y/Y for October
• 10:30 AM ET                 Weekly EIA Natural Gas Inventory Data (pushed out due to Veteran’s Day holiday)
• 1:00 PM ET                    Baker Hughes Weekly rig count data

• Stifel Healthcare Conference, 11/11-11/13, in New York

.